Literature DB >> 25252318

Living with uncertainty: antidepressants and pregnancy.

Ian Jones1, Liz McDonald1.   

Abstract

There have been a large number of studies in recent years reporting on the reproductive safety of antidepressant medication. Some studies, but not all, have reported an association of antidepressant exposure in pregnancy and the subsequent development of autism spectrum disorders. It remains difficult to know whether the modest increase in risk is due to the medication, to the mood disorder itself, or to other confounding factors. For any individual woman the decision to commence or continue antidepressant medication in pregnancy must be made after a full consideration of the potential risks and benefits of all options, including non-pharmacological treatments. In making these difficult decisions it is important to recognise that episodes of severe psychiatric illness may have very serious negative consequences for the woman, her baby and her family, and these must be weighed against what is known about the risks of taking medication. Royal College of Psychiatrists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25252318     DOI: 10.1192/bjp.bp.113.141713

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  2 in total

1.  Greater number of group identifications is associated with lower odds of being depressed: evidence from a Scottish community sample.

Authors:  Fabio Sani; Vishnu Madhok; Michael Norbury; Pat Dugard; Juliet R H Wakefield
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-06-10       Impact factor: 4.328

Review 2.  Optimizing the treatment of mood disorders in the perinatal period.

Authors:  Samantha Meltzer-Brody; Ian Jones
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.